A multi-centre evaluation of eleven clinically feasible brain PET/MRI attenuation correction techniques using a large cohort of patients

Research output: Contribution to journalJournal articleResearchpeer-review

  • Claes Nøhr Ladefoged
  • Udunna Anazodo
  • Keith St. Lawrence
  • David Izquierdo-Garcia
  • Ciprian Catana
  • Ninon Burgos
  • Manuel Jorge Cardoso
  • Sebastien Ourselin
  • Brian Hutton
  • Inés Mérida
  • Nicolas Costes
  • Alexander Hammers
  • Didier Benoit
  • Meher Juttukonda
  • Hongyu An
  • Jorge Cabello
  • Mathias Lukas
  • Stephan Nekolla
  • Sibylle Ziegler
  • Matthias Fenchel
  • Björn Jakoby
  • Michael E. Casey
  • Tammie Benzinger
  • Adam E. Hansen
  • Flemming L Andersen

Aim: To accurately quantify the radioactivity concentration measured by PET, emission data need to be corrected for photon attenuation; however, the MRI signal cannot easily be converted into attenuation values, making attenuation correction (AC) in PET/MRI challenging. In order to further improve the current vendor-implemented MR-AC methods for absolute quantification, a number of prototype methods have been proposed in the literature. These can be categorized into three types: template/atlas-based, segmentation-based, and reconstruction-based. These proposed methods in general demonstrated improvements compared to vendor-implemented AC, and many studies report deviations in PET uptake after AC of only a few percent from a gold standard CT-AC. Using a unified quantitative evaluation with identical metrics, subject cohort, and common CT-based reference, the aims of this study were to evaluate a selection of novel methods proposed in the literature, and identify the ones suitable for clinical use. 

Methods: In total, 11 AC methods were evaluated: two vendor-implemented (MR-ACDIXON and MR-ACUTE), five based on template/atlas information (MR-ACSEGBONE (Koesters et al., 2016), MR-ACONTARIO (Anazodo et al., 2014), MR-ACBOSTON (Izquierdo-Garcia et al., 2014), MR-ACUCL (Burgos et al., 2014), and MR-ACMAXPROB (Merida et al., 2015)), one based on simultaneous reconstruction of attenuation and emission (MR-ACMLAA (Benoit et al., 2015)), and three based on image-segmentation (MR-ACMUNICH (Cabello et al., 2015), MR-ACCAR-RiDR (Juttukonda et al., 2015), and MR-ACRESOLUTE (Ladefoged et al., 2015)). We selected 359 subjects who were scanned using one of the following radiotracers: [18F]FDG (210), [11C]PiB (51), and [18F]florbetapir (98). The comparison to AC with a gold standard CT was performed both globally and regionally, with a special focus on robustness and outlier analysis. 

Results: The average performance in PET tracer uptake was within ±5% of CT for all of the proposed methods, with the average±SD global percentage bias in PET FDG uptake for each method being: MR-ACDIXON (−11.3±3.5)%, MR-ACUTE (−5.7±2.0)%, MR-ACONTARIO (−4.3±3.6)%, MR-ACMUNICH (3.7±2.1)%, MR-ACMLAA (−1.9±2.6)%, MR-ACSEGBONE (−1.7±3.6)%, MR-ACUCL (0.8±1.2)%, MR-ACCAR-RiDR (−0.4±1.9)%, MR-ACMAXPROB (−0.4±1.6)%, MR-ACBOSTON (−0.3±1.8)%, and MR-ACRESOLUTE (0.3±1.7)%, ordered by average bias. The overall best performing methods (MR-ACBOSTON, MR-ACMAXPROB, MR-ACRESOLUTE and MR-ACUCL, ordered alphabetically) showed regional average errors within ±3% of PET with CT-AC in all regions of the brain with FDG, and the same four methods, as well as MR-ACCAR-RiDR, showed that for 95% of the patients, 95% of brain voxels had an uptake that deviated by less than 15% from the reference. Comparable performance was obtained with PiB and florbetapir. 

Conclusions: All of the proposed novel methods have an average global performance within likely acceptable limits (±5% of CT-based reference), and the main difference among the methods was found in the robustness, outlier analysis, and clinical feasibility. Overall, the best performing methods were MR-ACBOSTON, MR-ACMAXPROB, MR-ACRESOLUTE and MR-ACUCL, ordered alphabetically. These methods all minimized the number of outliers, standard deviation, and average global and local error. The methods MR-ACMUNICH and MR-ACCAR-RiDR were both within acceptable quantitative limits, so these methods should be considered if processing time is a factor. The method MR-ACSEGBONE also demonstrates promising results, and performs well within the likely acceptable quantitative limits. For clinical routine scans where processing time can be a key factor, this vendor-provided solution currently outperforms most methods. With the performance of the methods presented here, it may be concluded that the challenge of improving the accuracy of MR-AC in adult brains with normal anatomy has been solved to a quantitatively acceptable degree, which is smaller than the quantification reproducibility in PET imaging.

Original languageEnglish
Pages (from-to)346-359
Number of pages14
Publication statusPublished - 15 Feb 2017

    Research areas

  • Attenuation correction, Brain, PET/MRI

Number of downloads are based on statistics from Google Scholar and www.ku.dk

No data available

ID: 180826060